Immix Biopharma, Inc. (IMMX) (CIK 0001873835) UPLOAD
An UPLOAD letter is the SEC's written comment to the company during a filing review. SEC staff flag accounting issues, ICFR weaknesses, segment-reporting disputes, and revenue-recognition concerns here. Released to EDGAR 20 days after the SEC closes its review.
Key facts
- Accession number
- 0000000000-26-000603
- Form
- UPLOAD
- Filer
- Immix Biopharma, Inc. (IMMX) (CIK 0001873835)
- CIK
- 0001873835
- Ticker
- IMMX
- Filed
- 2026-01-16
- SEC file number
- 333-292665
- SIC industry
- 2834
- HQ
- Los Angeles, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1873835/000000000026000603/filename1.pdf
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer